← All stocks

ANAVEX LIFE SCIENCES CORP.

AVXL Mostly scheduled

CIK 0001314052 #3627 in the set updated 22 Sep 2026

Bought (120 mo)

$113.06K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$12.27M

$0.00 on a plan · $12.27M straight out of an exercise

Sold at will

$0.00

0 of 7 sales

Net

−$12.16M

+$113.06K against sales at will

By person

6 insiders · 42 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Boenisch Sandra

PFO & Treasurer

—

$4.42M (1) scheduled

−$4.42M

22,963

0.0257%

$83.59K

0.0%

MISSLING CHRISTOPHER U

President and CEO

$54.45K (26)

$3.86M (3) scheduled

−$3.80M

1,510,165

1.69%

$5.50M

+50.5%

FAVUS ELLIOT

Director

—

$3.54M (2) scheduled

−$3.54M

0.0000%

$0.00

—

Skarpelos Athanasios

Director

—

$453.00K (1) scheduled

−$453.00K

1,306,458

1.46%

$4.76M

0.0%

Donhauser Peter D.O.

Director

$36.01K (4)

—

+$36.01K

5,000

0.0056%

$18.20K

—

Thomas Steffen

Director

$22.60K (1)

—

+$22.60K

43,651

0.0489%

$158.89K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 118

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 7

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 2,308,590

History held since 26 Sep 2016